Ponticelli regimen for idiopathic membranous nephropathy

Anapalahan, M.; Weerasinghe, G.A.K.; Casinadar, J.K.; Priyanthi, W.; Nanayakkara, S.; Sheriff, M.H.R.

dc.contributor.author	Anapalahan, M.
dc.contributor.author	Weerasinghe, G.A.K.
dc.contributor.author	Casinadar, J.K.
dc.contributor.author	Priyanthi, W.
dc.contributor.author	Nanayakkara, S.
dc.contributor.author	Sheriff, M.H.R.
dc.date.accessioned	2012-02-17T04:46:48Z
dc.date.available	2012-02-17T04:46:48Z
dc.date.issued	1991
dc.identifier.citation	Sri Lanka Medical Association -104th Anniversary Academic Sessions; 1991_.43pp	en_US
dc.identifier.uri	http://archive.cmb.ac.lk:8080/xmlui/handle/70130/1839
dc.description.abstract	Idiopathic Membranous Nephropathy is common glomerular disease in adults and occurs world wide. Various treatment protocols including high dose alternate day steroids, cyclophosphamide had been used with varying success rates. The ponticelli regimen has replaced above methods of treatment and today is widely accepted as a successful treatment regimen in Idiopathic Membrane Nephropathy. The treatment regime consists of monthly corticosteroids alternating with chlorambucil (0.2mg per kilogram of body weight per day) for six months. Monthly steroid treatment consists of methyl prednisolone in 1 gram pulses for three days. Followed by oral prednisolone (0.5 mg per kilogram of body weight per day) for days. Our patient was started on treatment in August 1990 and his clinical course is described. This regimen has not been reported previously in Sri Lanka.
dc.language.iso	en	en_US
dc.title	Ponticelli regimen for idiopathic membranous nephropathy	en_US
dc.type	Research abstract	en_US